Literature DB >> 33734352

Major left ventricular thrombi in an adolescent with COVID-19-associated inflammatory syndrome.

Ondřej Materna1, Karel Koubský1, Radek Pádr2, Jan Janoušek1.   

Abstract

Entities:  

Year:  2021        PMID: 33734352      PMCID: PMC7989523          DOI: 10.1093/eurheartj/ehab165

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
Seventeen-year-old boy with a recent history of mild course of COVID-19 (polymerase chain reaction positivity) was admitted to a regional hospital after 6 days of fever, diarrhoea, highly elevated C-reactive protein, fibrinogen, D-dimers, Troponin T, NT-proBNP, and SARS-COV-2 antibodies. Initial echocardiography showed impaired left ventricular (LV) function (ejection fraction 37%) without electrocardiographic signs of acute myocardial infarction. Inotropic support was started, intravenous immunoglobulins 2 g/kg, corticosteroids and preventive dose of nadroparin were administered. Echocardiography 42 h later showed normalization of the LV function and multiple thrombi in the LV apex. Heparin was started and the patient was transferred to our institution. At least four large mobile thrombi were detected (Panels A and B). Surgical extraction was considered high risk; therefore, Alteplase was administered in the cathlab after bilateral carotid filter insertion. Embolized thrombi were subsequently extracted from one filter and from the right femoral artery. On Day 4, residual thrombus embolized into the right medial cerebral artery followed by urgent interventional recanalization within 60 min (Panel C). Two more vascular surgical procedures for peripheral embolus extraction were required later. Echocardiography showed no residual LV thrombi (Panel D). The patient is in full contact and has partial paresis of left-sided limbs. There is no family history of thrombo-embolism; patient’s current coagulation profile, platelets count and protein C and S levels are normal. Genetic testing for thrombophilia is negative. This is to our knowledge the first described case of LV thrombi in an adolescent associated with COVID-19-associated inflammatory syndrome without myocardial infarction. Panel A: Short axis view showing thrombi in the apex of the left ventricle (arrows). Panel B: Four-chamber view showing thrombi in the apex of the left ventricle (arrows). Panel C: Angiography showing occlusion of the right medial cerebral artery (1). Recanalized right medial cerebral artery on angiography (2) and subsequent MRI (3). R, right; L, left. Panel D: Four-chamber view showing no residual thrombi in the left ventricle. Funding: This work was supported by Ministry of Health, Czech Republic—Conceptual Development of Research Organization, Motol University Hospital, Prague (00064203). Conflict of interest: The authors have submitted their declaration which can be found in the article Supplementary Material online. Click here for additional data file.
  2 in total

1.  Left ventricular thrombus in the multisystem inflammatory syndrome in children associated with COVID-19.

Authors:  Spencer B Barfuss; Dongngan T Truong; Karen E James; Christi J Inman; S Adil Husain; Richard V Williams; L LuAnn Minich; Christopher R Mart
Journal:  Ann Pediatr Cardiol       Date:  2022-06-14

Review 2.  A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection.

Authors:  Anil Mathew Philip; Lina James George; Kevin John John; Anu Anna George; Jemimah Nayar; Kamal Kant Sahu; Vijairam Selvaraj; Amos Lal; Ajay Kumar Mishra
Journal:  J Clin Transl Res       Date:  2021-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.